P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION.

• Mahesh Swaminathan,
• Rashmi Kanagal-Shamanna,
• Farhad Ravandi,
• Tapan Kadia,
• Courtney Dinardo,
• Naval Daver,
• Naveen Pemmaraju,
• Elias Jabbour,
• Sherry Pierce,
• John Matthew Villareal,
• Gautam Borthakur

Affiliations

Mahesh Swaminathan

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Rashmi Kanagal-Shamanna

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Farhad Ravandi

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Tapan Kadia

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Courtney Dinardo

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Naval Daver

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Naveen Pemmaraju

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Elias Jabbour

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Sherry Pierce

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

John Matthew Villareal

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Gautam Borthakur

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States